Directors

The Directors team at Outlook Therapeutics encompasses a range of specialized leaders responsible for overseeing critical functions such as human resources, patient access and marketing, bioassay development, clinical affairs, physician relations, and financial planning and analysis. This team ensures strategic alignment and operational efficiency across various departments to support the clinical development and potential FDA approval of ONS-5010 / LYTENAVA™ (bevacizumab-vikg).